Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study.

IF 3.5 2区 医学 Q1 RHEUMATOLOGY Lupus Science & Medicine Pub Date : 2025-02-26 DOI:10.1136/lupus-2024-001361
Soo-Kyung Cho, Yena Jeon, Jung-Hyo Kim, Eun Jin Jang, Sun-Young Jung, Yoon-Kyoung Sung
{"title":"Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study.","authors":"Soo-Kyung Cho, Yena Jeon, Jung-Hyo Kim, Eun Jin Jang, Sun-Young Jung, Yoon-Kyoung Sung","doi":"10.1136/lupus-2024-001361","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the mortality patterns of SLE and the associated risk factors in Koreans.</p><p><strong>Methods: </strong>Using the National Health Insurance database spanning 2008 to 2018, incident cases of SLE in patients aged 10-79 years were included. We analysed the all-cause mortality and cause-specific mortality, stratifying by sex and age. The mortality rate (MR) was calculated as the number of deaths per 100 000 person-years (PYs). The causes of death were identified by the International Classification of Diseases, 10th Revision codes during hospitalisation or emergency visit prior to death. A generalised estimating equation model was employed for risk factor analysis.</p><p><strong>Results: </strong>In total, 11 375 incident SLE cases among patients with an average age of 42.3±16.7 years were recruited (86.1% female). During 57 658 PYs, 728 deaths occurred (MR 1262.62/100 000 PYs). The MR among men (2718.86/100 000 PYs) exceeded that among women (1060.57/100 000 PYs). The leading causes of death were SLE-related conditions (381.56/100 000 PYs), cardiovascular disease (CVD) (202.92/100 000 PYs), cancer (175.17/100 000 PYs) and infection (143.95/100 000 PYs). Of the SLE-related mortality, the key risk factors were pulmonary complications, such as pulmonary alveolar haemorrhage (OR 9.93), pulmonary arterial hypertension (OR 3.77) and interstitial lung disease (OR 3.27).</p><p><strong>Conclusions: </strong>Among Korean patients with SLE, SLE-related conditions were the leading causes of mortality. However, CVD and cancer were also identified as the main causes of mortality. Furthermore, pulmonary manifestations were significantly associated with SLE-related mortality.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"12 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865735/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2024-001361","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To evaluate the mortality patterns of SLE and the associated risk factors in Koreans.

Methods: Using the National Health Insurance database spanning 2008 to 2018, incident cases of SLE in patients aged 10-79 years were included. We analysed the all-cause mortality and cause-specific mortality, stratifying by sex and age. The mortality rate (MR) was calculated as the number of deaths per 100 000 person-years (PYs). The causes of death were identified by the International Classification of Diseases, 10th Revision codes during hospitalisation or emergency visit prior to death. A generalised estimating equation model was employed for risk factor analysis.

Results: In total, 11 375 incident SLE cases among patients with an average age of 42.3±16.7 years were recruited (86.1% female). During 57 658 PYs, 728 deaths occurred (MR 1262.62/100 000 PYs). The MR among men (2718.86/100 000 PYs) exceeded that among women (1060.57/100 000 PYs). The leading causes of death were SLE-related conditions (381.56/100 000 PYs), cardiovascular disease (CVD) (202.92/100 000 PYs), cancer (175.17/100 000 PYs) and infection (143.95/100 000 PYs). Of the SLE-related mortality, the key risk factors were pulmonary complications, such as pulmonary alveolar haemorrhage (OR 9.93), pulmonary arterial hypertension (OR 3.77) and interstitial lung disease (OR 3.27).

Conclusions: Among Korean patients with SLE, SLE-related conditions were the leading causes of mortality. However, CVD and cancer were also identified as the main causes of mortality. Furthermore, pulmonary manifestations were significantly associated with SLE-related mortality.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
韩国患者SLE死亡模式及相关危险因素:一项全国性队列研究
背景:评价韩国SLE患者的死亡模式及相关危险因素。方法:使用2008年至2018年的国家健康保险数据库,纳入10-79岁SLE患者的事件病例。我们分析了全因死亡率和特定原因死亡率,按性别和年龄分层。死亡率(MR)计算为每10万人年(PYs)的死亡人数。死亡原因在死亡前住院或急诊期间由《国际疾病分类第十次修订代码》确定。采用广义估计方程模型进行风险因素分析。结果:共纳入11375例SLE患者,平均年龄42.3±16.7岁,其中女性占86.1%。在57 658年期间,发生728例死亡(死亡率为1262.62/100 000年)。男性MR(2718.86/10万PYs)高于女性MR(1060.57/10万PYs)。死亡原因主要为sle相关疾病(381.56/10万PYs)、心血管疾病(202.92/10万PYs)、癌症(175.17/10万PYs)和感染(143.95/10万PYs)。sle相关死亡率的主要危险因素为肺部并发症,如肺泡出血(OR 9.93)、肺动脉高压(OR 3.77)和间质性肺疾病(OR 3.27)。结论:在韩国SLE患者中,SLE相关疾病是导致死亡的主要原因。然而,心血管疾病和癌症也被确定为死亡的主要原因。此外,肺部表现与sle相关的死亡率显著相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
期刊最新文献
Conditions identified by common comprehensive geriatric assessment measures and subsequent acute care among adults with SLE. Unsupervised clustering of clinical and laboratory features of systemic lupus erythematosus: insights from a multicentre cohort. Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials. Comparison of Evans syndrome and isolated autoimmune cytopenias in SLE: a retrospective study. Pulmonary diseases in SLE: a population-based cross-sectional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1